See every side of every news story
Published loading...Updated

Opportunities rise for LivaNova in CPBE market as Getinge surgical perfusion exit: GlobalData

Summary by Express Healthcare
Swedish medtech company Getinge’s decision to exit the surgical perfusion business signals a strategic shift toward higher-growth areas like extracorporeal membrane oxygenation (ECMO). This move is set to benefit dominant players like LivaNova, which is well-positioned to capture the market share in the cardiopulmonary bypass equipment (CBPE) sector, which continues to show steady growth driven by technological advancements and the ageing popula…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

2 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

GlobalData broke the news in on Thursday, February 20, 2025.
Sources are mostly out of (0)